HKSE:01652 has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
HKSE:01652 has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Fusen Pharmaceutical Co's book value per share for the quarter that ended in Dec. 2023 was HK$0.83.
During the past 12 months, Fusen Pharmaceutical Co's average Book Value Per Share Growth Rate was -8.50% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -6.40% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -1.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.
During the past 9 years, the highest 3-Year average Book Value Per Share Growth Rate of Fusen Pharmaceutical Co was 76.60% per year. The lowest was -6.40% per year. And the median was 25.75% per year.
Fusen Pharmaceutical Co's current price is HK$1.00. Its book value per share for the quarter that ended in Dec. 2023 was HK$0.83. Hence, today's PB Ratio of Fusen Pharmaceutical Co is 1.21.
During the past 9 years, the highest P/B Ratio of Fusen Pharmaceutical Co was 9.18. The lowest was 0.87. And the median was 2.64.
The historical data trend for Fusen Pharmaceutical Co's Book Value per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fusen Pharmaceutical Co Annual Data | |||||||||||||||||||
Trend | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | ||||||||||
Book Value per Share | Get a 7-Day Free Trial | 0.94 | 1.01 | 1.05 | 0.90 | 0.83 |
Fusen Pharmaceutical Co Semi-Annual Data | ||||||||||||||||
Dec15 | Dec16 | Jun17 | Dec17 | Jun18 | Dec18 | Jun19 | Dec19 | Jun20 | Dec20 | Jun21 | Dec21 | Jun22 | Dec22 | Jun23 | Dec23 | |
Book Value per Share | Get a 7-Day Free Trial | 1.05 | 1.00 | 0.90 | 0.90 | 0.83 |
For the Drug Manufacturers - Specialty & Generic subindustry, Fusen Pharmaceutical Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Drug Manufacturers industry and Healthcare sector, Fusen Pharmaceutical Co's PB Ratio distribution charts can be found below:
* The bar in red indicates where Fusen Pharmaceutical Co's PB Ratio falls into.
Fusen Pharmaceutical Co's Book Value Per Share for the fiscal year that ended in Dec. 2023 is calculated as:
Book Value Per Share | = | (Total Stockholders Equity | - | Preferred Stock) | / | Shares Outstanding (EOP) |
= | (616.4 | - | 0.0) | / | 745.0 | |
= | 0.83 |
Fusen Pharmaceutical Co's Book Value Per Share for the quarter that ended in Dec. 2023 is calculated as:
Book Value Per Share | = | (Total Stockholders Equity | - | Preferred Stock) | / | Shares Outstanding (EOP) |
= | (616.4 | - | 0.0) | / | 745.0 | |
= | 0.83 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.
Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.
Fusen Pharmaceutical Co (HKSE:01652) Book Value per Share Explanation
Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.
For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.
Thank you for viewing the detailed overview of Fusen Pharmaceutical Co's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Cao Changcheng | 2201 Interest of corporation controlled by you | |
Quan Xiufeng | 2202 Interest of your spouse | |
Full Bliss Holdings Limited | 2101 Beneficial owner | |
One Victory Investments Limited | 2101 Beneficial owner | |
Cao Zhiming | 2201 Interest of corporation controlled by you | |
Zhou Peilin | 2202 Interest of your spouse | |
Rayford Global Limited | 2306 Nominee for another person | |
Tct (bvi) Limited | 2501 Other | |
The Core Trust Company Limited | 2301 Trustee | |
First Joint Elegant Limited | 2101 Beneficial owner | |
Fung Wai Sze | 2202 Interest of your spouse | |
Lam Yiu Por | 2201 Interest of corporation controlled by you |
No Headlines
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.